Vascular Function and Uterine Fibroids
- Conditions
- Leiomyoma
- Interventions
- Device: Brachial artery catheter
- Registration Number
- NCT02123069
- Lead Sponsor
- Mayo Clinic
- Brief Summary
The purpose of this study is to learn how uterine fibroids may be connected to heart disease and high blood pressure. It is not known what causes fibroids, but they frequently occur in women who also have high blood pressure, heart disease, and stroke. The investigators of this study want to learn if certain changes in the blood vessels or nerve activity can put women at risk for these diseases and for fibroids.
- Detailed Description
The investigators are inviting women, 25-50 years old, who have not gone through menopause to participate in this study. The investigators are looking for some women with uterine fibroids and some without uterine fibroids based on ultrasound or MRI. If the patients have not had a recent ultrasound or MRI of the uterus, a physician can provide one.
Individuals cannot participate if they have high blood pressure, diabetes, or disease in the kidneys, lungs, or blood vessels. Also, individuals who smoke, have high cholesterol, or are obese (BMI is higher than 30) cannot participate. Certain medications, including high blood pressure medications, beta-blockers and anti-depressants, will also limit potential patient participation. The investigators would be happy to review medications for potential participants.
Screen Day:
One of the members of the research team will review the study and the informed consent document with the patient. The patient will have their height, weight, blood pressure, pulse and respirations measured. The patient will also complete three questionnaires. If the patient has not had an ultrasound of the uterus in the last 12 months, a physician will complete one for her.
Study Day:
The patient will need to fast overnight (no eating or drinking). The investigators will draw a blood sample and then do a series of tests on the participant's blood vessels. For some of the tests, medication will be given through an IV. The investigators will also test nerve activity in the nerve on the outer aspect of the leg.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Female
- Target Recruitment
- 28
- Women 25-50 years old
- Premenopausal
- Postmenopausal
- Pregnant or currently breastfeeding
- Using blood pressure medications or anti-depression medications
- High blood pressure
- Diabetes
- Disease in the kidneys, lungs, or blood vessels
- Chronic diseases (for example: Crohn's disease, rheumatoid arthritis, bipolar mood disorder, etc.)
- Smoker
- High cholesterol
- BMI higher than 30
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Women without uterine fibroids Nitroprusside and phenylephrine * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine Women without uterine fibroids Brachial artery catheter * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine Women with uterine fibroids Brachial artery catheter * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine Women with uterine fibroids Nitroprusside and phenylephrine * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine Women with uterine fibroids Norepinephrine * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine Women with uterine fibroids Nitroprusside * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine Women without uterine fibroids Nitroprusside * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine Women without uterine fibroids Norepinephrine * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine Women with uterine fibroids Acetylcholine * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine Women without uterine fibroids Acetylcholine * Brachial artery catheter * Acetylcholine * Nitroprusside * Norepinephrine * Nitroprusside and phenylephrine
- Primary Outcome Measures
Name Time Method Baseline sympathetic nerve activity One day (study day) Nerve "burst" activity will be measured across 10 minutes.
Baseline systolic, diastolic, and mean blood pressures One day (study day)
- Secondary Outcome Measures
Name Time Method Changes in forearm blood flow levels in response to acetylcholine infusion One day (study day) Pulse wave velocity (an index of vessel stiffness) One day (study day) Changes in forearm blood flow levels in response to nitroprusside infusion One day (study day) Changes in forearm blood flow levels in response to norepinephrine infusion One day (study day) Change in blood pressure in response to infusions of nitroprusside and phenylephrine One day (study) An infusion of nitroprusside will be given, followed by an infusion of phenylephrine one minute later.
Trial Locations
- Locations (1)
Mayo Clinic
🇺🇸Rochester, Minnesota, United States
Mayo Clinic🇺🇸Rochester, Minnesota, United States